The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Canada House Wellness Group Inc. (the “Company”) is the parent company of 672800 NB Inc. doing business as Canada House Clinics Inc., Knalysis Technologies Inc. and Abba Medix Corp. Through their vertically integrated subsidiaries, the Company’s goal is to become a marketplace leader in the delivery and support of evidence based, client focused cannabinoid therapy. For more information please visit www.canadahouse.ca.
Based in Vancouver BC, Canna-V-cell sciences (CNVC) is the exclusive Cannabis worldwide licensee of the proprietary and patent protected BioHarvest technology. It is the first and only industrial large scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself.
The Issuer is an investment corporation which seeks to provide shareholders long-term total return through capital appreciation by investing in an actively managed portfolio of securities of public and private companies operating in, or that derive a significant portion of their revenue or earnings from, products or services related to the cannabis industry.
CannAmerica Brands Corp. is a U.S. marine veteran founded and operated portfolio of cannabis brands with licensing agreements in the states of Colorado, Nevada and Maryland. CannAmerica aims to maximize the value of its brands by employing strong brand management teams, marketing and licensing the brands through various distribution channels, including dispensaries, wholesalers and distributors, in the United States and internationally.
Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility.
Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.
Cannex was founded in 2017 and is managed by a team of experienced industry and capital markets experts who are committed to aggressive, cost-effective growth. Cannex intends to facilitate growth through cash flow from operations, strategic acquisitions and partnerships and by leveraging the expertise of its experienced operational team. Cannex will focus on providing a range of comprehensive and flexible growth options for licensed cannabis cultivators, processors and/or dispensaries domestically and internationally, including providing turn-key real estate with operational infrastructure as well as long term advisory and consulting services.
Class A Shares
The total number of outstanding shares does not include 96,521,733 Class A convertible restricted voting shares (the “Class A Shares”) that are issued and outstanding. The Class A Shares are held by U.S. residents and there are restrictions on the ability of U.S. residents to convert such shares into common shares.
The holders of the Class A Shares are entitled to receive notice of and to attend all meetings of the shareholders. The holders of Class A Shares are entitled to one vote per Class A Share at any meeting of the shareholders provided that the holders of the Class A Shares will not be entitled to vote for the election or removal of the directors. Please see Section 10 – Description of Securities, of Cannex’s Form 2A Listing Statement for a further description of the Class A Shares.
Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.
Cannvas MedTech Inc. is a leading business technology company within the cannabis space. The company designs and builds customer-centric solutions that enable its partners to harness the power of data to truly understand their customers, industry, and key business drivers.